Search results for "epigenetic"

showing 10 items of 632 documents

8th SIBBM Seminar - Frontiers in Molecular Biology - Epigenetics in Development and Disease

2012

EpigeneticSettore BIO/11 - Biologia MolecolareDevelopmentMolecular Biology; Epigenetics; DevelopmentMolecular Biology
researchProduct

Le linee cellulari V79 e Caco-2: due modelli per studi in vitro di epi-mutagenesi

2020

È da pochi anni noto che alcune sostanze, non classificabili come veri e propri mutageni, sono in realtà dei modulatori epigenetici ed inducono cambiamenti nella metilazione del DNA, nella acetilazione/deacetilazione degli istoni e possono modificare la sintesi endocellulare di alcuni miRNA. Inducendo modificazioni epigenetiche non causano mutazioni genetiche, sfuggono ai test di mutagenesi e carcinogenesi fino ad ora utilizzati ma possono ugualmente avere effetti fenotipici simili a quelli di un mutageno/carcinogeno. Per anni l’arsenico, noto veleno ad alte dosi, contaminante obbligato delle acque potabili, è stato oggetto di dibattiti sulla sua mutagenicità a basse dosi. Utilizzato, parad…

Epigenetica linee cellulari arsenicoSettore BIO/18 - Genetica
researchProduct

Methylation status of VTRNA2-1/nc886 is stable across populations, monozygotic twin pairs and in majority of tissues. Supplementary data

2022

Supplementary Table 1. This study used 48 DNA methylation datasets, including DILGOM, FTC, ERMA, KORA, LURIC, NELLI, SATSA and YFS as well as 39 datasets available in the Gene Expression Omnibus (GEO) [29] consisting of >30 tissues and >30,000 individuals. Supplementary Table 2. Differences in the proportion of individuals with imprinted nc886 locus between sexes or in a case–control setting. Supplementary Table 3. Of these discordant pairs, one co-twin was always intermediately methylated, whereas the other co-twin was either imprinted or nonmethylated in all cases – that is, no twin pairs were identified in which one co-twin was imprinted and the other was nonmethylated. Supplementa…

Epigenetics (incl. genome methylation and epigenomics)
researchProduct

Developmental programming of adult haematopoiesis system

2019

The Barker hypothesis of ‘foetal origin of adult diseases’ has led to emphasize the concept of ‘developmental programming’, based on the crucial role of epigenetic factors. Accordingly, it has been demonstrated that parental adversity (before conception and during pregnancy) and foetal factors (i.e., hypoxia, malnutrition and placental insufficiency) permanently modify the physiological systems of the progeny, predisposing them to premature ageing and chronic disease during adulthood. Thus, an altered functionality of the endocrine, immune, nervous and cardiovascular systems is observed in the progeny. However, it remains to be understood whether the haematopoietic system itself also repres…

Epigenomics0301 basic medicineAgingHaematopoietic systemPro-health interventionHematopoietic SystemAgeing-related diseasePsychological interventionPlacental insufficiencyBiochemistryFoetal programmingDevelopmental psychologyFetal Development03 medical and health sciences0302 clinical medicinePregnancymedicineSettore MED/05 - Patologia ClinicaAnimalsHumansEndocrine systemEpigeneticsMolecular BiologyPregnancySettore BIO/11business.industryEpigeneticmedicine.diseaseHaematopoiesisMalnutrition030104 developmental biologyNeurologyFemaleEpigeneticsbusinessDevelopmental programmingAgeing-related disease; Epigenetics; Foetal programming; Haematopoietic system; Pro-health intervention030217 neurology & neurosurgeryBiotechnologyAgeing Research Reviews
researchProduct

Detecting RNA modifications in the epitranscriptome: predict and validate

2017

RNA modifications are emerging players in the field of post-transcriptional regulation of gene expression, and are attracting a comparable degree of research interest to DNA and histone modifications in the field of epigenetics. We now know of more than 150 RNA modifications and the true potential of a few of these is currently emerging as the consequence of a leap in detection technology, principally associated with high-throughput sequencing. This Review outlines the major developments in this field through a structured discussion of detection principles, lays out advantages and drawbacks of new high-throughput methods and presents conventional biophysical identification of modifications …

Epigenomics0301 basic medicineComputational biologyBiologyEpigenesis Genetic03 medical and health sciences0302 clinical medicine[SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry Molecular Biology/Genomics [q-bio.GN]EpitranscriptomicsGeneticsAnimalsHumansEpigeneticsRNA Processing Post-TranscriptionalMolecular BiologyComputingMilieux_MISCELLANEOUSGenetics (clinical)GeneticsRNA[SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry Molecular Biology/Molecular biologyComputingMethodologies_PATTERNRECOGNITION030104 developmental biologyGene Expression RegulationRNAIdentification (biology)Transcriptome030217 neurology & neurosurgeryNature Reviews Genetics
researchProduct

Positioning Europe for the EPITRANSCRIPTOMICS challenge

2018

WOS: 000444092300018 PubMed ID: 29671387 The genetic alphabet consists of the four letters: C, A, G, and T in DNA and C,A,G, and U in RNA. Triplets of these four letters jointly encode 20 different amino acids out of which proteins of all organisms are built. This system is universal and is found in all kingdoms of life. However, bases in DNA and RNA can be chemically modified. In DNA, around 10 different modifications are known, and those have been studied intensively over the past 20years. Scientific studies on DNA modifications and proteins that recognize them gave rise to the large field of epigenetic and epigenomic research. The outcome of this intense research field is the discovery t…

Epigenomics0301 basic medicine[SDV]Life Sciences [q-bio]Gene ExpressionDetection of RNA ModificationEpigenesis GeneticTranscriptomechemistry.chemical_compoundEcologyEvolution & EthologyNeoplasmsRNA NeoplasmEuropean FundingComputingMilieux_MISCELLANEOUSRNA Neoplasm/geneticsEpitranscriptomicsEpigenomicsStem CellsDNA NeoplasmNeoplasms/genetics[SDV] Life Sciences [q-bio]EuropeGene Expression Regulation NeoplasticDetection of RNA modificationGenetics & GenomicsComputational biologyBiologyBiochemistry & ProteomicsENCODE03 medical and health sciencesEpigenomics/standardsEpitranscriptomicsModel systemsHumansEpigeneticsDatabase of ModificationDNA Neoplasm/geneticsMolecular BiologyComputational & Systems BiologyEuropean funding[SDV.GEN]Life Sciences [q-bio]/GeneticsGene Expression ProfilingFOS: Clinical medicineNeurosciencesModel SystemsRNACell Biology030104 developmental biologychemistryGene Expression Profiling/methodsAlphabetTranscriptomeDNARNA Biology
researchProduct

The Association Between Epigenetic Clocks and Physical Functioning in Older Women: A 3-Year Follow-up

2021

Abstract Background Epigenetic clocks are composite markers developed to predict chronological age or mortality risk from DNA methylation (DNAm) data. The present study investigated the associations between 4 epigenetic clocks (Horvath’s and Hannum’s DNAmAge and DNAm GrimAge and PhenoAge) and physical functioning during a 3-year follow-up. Method We studied 63- to 76-year-old women (N = 413) from the Finnish Twin Study on Aging. DNAm was measured from blood samples at baseline. Age acceleration (AgeAccel), that is, discrepancy between chronological age and DNAm age, was determined as residuals from linear model. Physical functioning was assessed under standardized laboratory conditions at b…

EpigenomicsAgingfyysinen toimintakykyEpigenesis Genetic03 medical and health sciences0302 clinical medicinePhysical functioningMedicineHumans030212 general & internal medicineEpigeneticsAssociation (psychology)030304 developmental biology0303 health sciencesbusiness.industryLinear modelRepeated measures designdNaMDNA MethylationMissing dataTwin studyDNA-metylaatioikääntyminenCross-Sectional Studiesepigenetiikkabiological aging3121 General medicine internal medicine and other clinical medicineFemaleGeriatrics and Gerontologybusinessepigenetic clockDemographyFollow-Up Studies
researchProduct

Genetic and Epigenetic Biomarkers for Diagnosis, Prognosis and Treatment of Metabolic Syndrome.

2021

Background: Metabolic syndrome is a clinical condition that deserves special attention because it puts the individual at high cardiovascular risk, especially heart attack and stroke. Considering precision medicine, it would be advisable to evaluate the individual cardio-metabolic risk by estimating the coexistence of risk factors (abdominal obesity, low level of High-Density Lipoprotein Cholesterol, High Triglycerides, and small dense Low-Density Lipoproteins sub-classes, hypertension, and elevated fasting glycemia), which could engrave on metabolism increasing cardiovascular mortality. Objective: To identify genetic and epigenetic biomarkers may assist in the possibility of helping follow…

EpigenomicsBioinformaticsEpigenesis GeneticGeneticDrug DiscoverymedicineHumansEpigeneticsAbdominal obesityPharmacologyInflammationMetabolic Syndromebusiness.industryEpigeneticEpigenomeDNA MethylationPrecision medicinemedicine.diseasePrognosisManagementDNA methylationHuman genomePersonalized medicineMetabolic Pathwaysmedicine.symptomMetabolic syndromebusinessBiomarkersCurrent pharmaceutical design
researchProduct

The first European interdisciplinary ewing sarcoma research summit.

2012

This is an open-access article distributed under the terms of the Creative Commons Attribution Non Commercial License.-- et al.

EpigenomicsCancer ResearchAlternative medicineMedizinComputingMilieux_LEGALASPECTSOFCOMPUTINGReview ArticleBioinformatics[SDV.BBM.BM] Life Sciences [q-bio]/Biochemistry Molecular Biology/Molecular biologydrug screen0302 clinical medicineDrug screenCancer genomicssignallingSarcomagenesis0303 health sciencessarcomagenesisSummitgeography.geographical_feature_categoryOpinion leadershipGenomicsLaboratory resultslcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensPrognosisanimal models3. Good healthAnimal modelsMetastatic Ewing SarcomaOncology030220 oncology & carcinogenesis[SDV.BBM.GTP] Life Sciences [q-bio]/Biochemistry Molecular Biology/Genomics [q-bio.GN]EpigeneticsSarcomaImmunotherapyPrioritizationmedicine.medical_specialty[SDV.CAN]Life Sciences [q-bio]/Cancerlcsh:RC254-28203 medical and health sciences[SDV.CAN] Life Sciences [q-bio]/Cancer[SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry Molecular Biology/Genomics [q-bio.GN]medicinegenomics030304 developmental biologyMedical educationgeographyepigeneticsbusiness.industrybiomarkers[SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry Molecular Biology/Molecular biologymedicine.diseaseClinical trialprognosisbusinessBiomarkersEwing sarcomaFrontiers in oncology
researchProduct

Astrocytes and neurons share region-specific transcriptional signatures that confer regional identity to neuronal reprogramming

2021

Region-specific gene expression shared with neurons imparts to astrocytes competence for region-specific neuronal reprogramming.

EpigenomicsCellThalamusNeocortexBiology03 medical and health sciences0302 clinical medicineThalamusGene expressionmedicineEpigeneticsProgenitor cellNeural cellResearch Articles030304 developmental biologyNeurons0303 health sciencesMultidisciplinaryNeocortexSciAdv r-articlesmedicine.anatomical_structurenervous systemAstrocytesNeuroscienceReprogramming030217 neurology & neurosurgeryResearch ArticleNeuroscience
researchProduct